Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile
- 1 June 2005
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 95 (s4), 1-5
- https://doi.org/10.1111/j.1464-410x.2005.05484.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progressionBJU International, 2005
- Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on α1‐adrenoceptor antagonistsBJU International, 2005
- Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular systemBJU International, 2005
- INTERACTION BETWEEN THE PHOSPHODIESTERASE 5 INHIBITOR, TADALAFIL AND 2 α-BLOCKERS, DOXAZOSIN AND TAMSULOSIN IN HEALTHY NORMOTENSIVE MENJournal of Urology, 2004
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003
- Long-Term Risk Of Re-Treatment Of Patients Using ??-Blockers For Lower Urinary Tract SymptomsJournal of Urology, 2002
- Introduction and Concluding RemarksEuropean Urology, 1999
- TAMSULOSIN TREATMENT OF 19,365 PATIENTS WITH LOWER URINARY TRACT SYMPTOMSJournal of Urology, 1998
- The International Continence Society "Benign Prostatic Hyperplasia" StudyJournal of Urology, 1997
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991